Neurable raises $35M Series A to Scale Brain-Computer Interface AI

The fresh capital will be used to accelerate the commercialization of Neurable’s brain-signal artificial intelligence technology and expand its applications across cognitive health sectors, including gaming and e-sports.

Boston-based brain-computer interface (BCI) technology company Neurable has raised $35 million in a Series A funding round, led by Spectrum Moonshot Fund, bringing its total funding to $65 million, the company announced on December 22.

The fresh capital will be used to accelerate the commercialization of Neurable’s brain-signal artificial intelligence technology and expand its applications across cognitive health sectors, including gaming and e-sports. The company said the funding will support the integration of its AI into new consumer devices and industries.

Neurable’s core offering, Neurable AI, uses brain-signal processing technology to embed BCI capabilities into everyday devices. The company positions its technology to provide real-time insights into brain activity without invasive hardware.

Among its commercial products is the MW75 Neuro LT, powered by Neurable AI, which works alongside a mobile application to deliver insights related to mental fatigue, cognitive recovery, and focus-state detection. The product is designed to help users track cognitive performance throughout the day using passive brain-signal data.

Commenting on the funding, Ramses Alcaide, CEO and cofounder of Neurable, said the company aims to make brain health monitoring part of everyday life. “Our mission is to make understanding your brain as natural and intuitive as checking your steps,” Alcaide said in a statement. He added that the latest funding will allow the company to scale its AI into new devices and industry verticals.

Beyond consumer products, Neurable has been expanding its presence in research and enterprise settings. In October, the company partnered with iMotions, a human behavior research software platform, integrating Neurable’s technology to enable real-world brain activity measurement and analysis. During the same month, workplace design company MeSpace named Neurable its official research partner to study the impact of workspace design on cognitive performance.

In terms of previous funding, Neurable raised $13 million last year from investors including Ultratech Capital Partners, TRAC, Pace Ventures, and Metaplanet.

The company has also pursued international healthcare collaborations. In 2024, Neurable partnered with Canadian precision health company Healthspan Digital to introduce its brain-computer interface technology into health and longevity clinics globally, starting in Dubai, with a focus on assessing brain health and cognitive performance in clinical and enterprise settings.

Stay tuned for more such updates on Digital Health News